22:21:32 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-27 Bokslutskommuniké 2024
2024-11-28 Kvartalsrapport 2024-Q3
2024-08-27 Kvartalsrapport 2024-Q2
2024-06-20 X-dag ordinarie utdelning AXIC A 0.00 SEK
2024-06-19 Årsstämma
2024-05-23 Kvartalsrapport 2024-Q1
2024-03-06 Extra Bolagsstämma 2024
2024-03-05 Bokslutskommuniké 2023
2023-11-22 Kvartalsrapport 2023-Q3
2023-08-23 Kvartalsrapport 2023-Q2
2023-06-19 X-dag ordinarie utdelning AXIC A 0.00 SEK
2023-06-16 Årsstämma
2023-05-24 Kvartalsrapport 2023-Q1
2023-02-23 Bokslutskommuniké 2022
2022-11-24 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-06-01 X-dag ordinarie utdelning AXIC A 0.00 SEK
2022-05-31 Årsstämma
2022-05-24 Kvartalsrapport 2022-Q1
2022-02-17 Bokslutskommuniké 2021
2021-11-11 Kvartalsrapport 2021-Q3
2021-08-31 Kvartalsrapport 2021-Q2
2021-05-31 X-dag ordinarie utdelning AXIC A 0.00 SEK
2021-05-28 Årsstämma
2021-05-20 Kvartalsrapport 2021-Q1
2021-02-24 Bokslutskommuniké 2020
2020-11-12 Kvartalsrapport 2020-Q3
2020-08-21 Kvartalsrapport 2020-Q2
2020-05-27 X-dag ordinarie utdelning AXIC A 0.00 SEK
2020-05-26 Årsstämma
2020-05-14 Kvartalsrapport 2020-Q1
2020-02-27 Bokslutskommuniké 2019
2019-11-14 Kvartalsrapport 2019-Q3
2019-08-29 Kvartalsrapport 2019-Q2
2019-05-29 X-dag ordinarie utdelning AXIC A 0.00 SEK
2019-05-28 Årsstämma
2019-05-23 Kvartalsrapport 2019-Q1
2019-02-27 Bokslutskommuniké 2018
2018-11-15 Kvartalsrapport 2018-Q3
2018-08-29 Kvartalsrapport 2018-Q2
2018-06-01 X-dag ordinarie utdelning AXIC A 0.00 SEK
2018-05-31 Årsstämma
2018-05-15 Kvartalsrapport 2018-Q1
2018-02-27 Bokslutskommuniké 2017
2017-11-23 Kvartalsrapport 2017-Q3
2017-08-24 Kvartalsrapport 2017-Q2
2017-06-01 X-dag ordinarie utdelning AXIC A 0.00 SEK
2017-05-31 Årsstämma
2017-05-31 Kvartalsrapport 2017-Q1
2017-05-24 Kvartalsrapport 2017-Q1
2017-02-23 Bokslutskommuniké 2016
2016-11-24 Kvartalsrapport 2016-Q3
2016-08-25 Kvartalsrapport 2016-Q2
2016-05-24 X-dag ordinarie utdelning AXIC A 0.00 SEK
2016-05-23 Årsstämma
2016-05-19 Kvartalsrapport 2016-Q1
2016-02-25 Bokslutskommuniké 2015
2015-11-25 Kvartalsrapport 2015-Q3
2015-08-26 Kvartalsrapport 2015-Q2
2015-05-29 X-dag ordinarie utdelning AXIC A 0.00 SEK
2015-05-28 Årsstämma
2015-05-25 Kvartalsrapport 2015-Q1
2015-02-26 Bokslutskommuniké 2014
2014-11-24 Kvartalsrapport 2014-Q3
2014-08-28 Kvartalsrapport 2014-Q2
2014-05-22 Årsstämma
2014-05-22 Kvartalsrapport 2014-Q1
2014-02-28 Bokslutskommuniké 2013
2013-11-29 Kvartalsrapport 2013-Q3
2013-08-26 Kvartalsrapport 2013-Q2
2013-06-28 Split AXIC A 4:1
2013-05-30 Kvartalsrapport 2013-Q1
2013-05-21 X-dag ordinarie utdelning AXIC A 0.00 SEK
2013-05-20 Årsstämma
2013-02-28 Bokslutskommuniké 2012
2012-11-26 Kvartalsrapport 2012-Q3
2012-08-30 Kvartalsrapport 2012-Q2
2012-05-28 Kvartalsrapport 2012-Q1
2012-05-17 X-dag ordinarie utdelning AXIC A 0.00 SEK
2012-05-16 Årsstämma
2012-02-29 Bokslutskommuniké 2011
2011-11-28 Kvartalsrapport 2011-Q3
2011-08-30 Kvartalsrapport 2011-Q2
2011-05-30 Kvartalsrapport 2011-Q1
2011-05-10 X-dag ordinarie utdelning AXIC A 0.00 SEK
2011-05-09 Årsstämma
2011-02-25 Bokslutskommuniké 2010
2010-05-11 X-dag ordinarie utdelning AXIC A 0.00 SEK

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorMaterial
IndustriPlast, kemikalier & fetter
aXichem är verksamt inom industriell bioteknik. Bolaget utvecklar, patenterar och marknadsför industrikemikalier. Bolaget arbetar framförallt med Fenylcapsaicin, en naturanalog syntetisk capsaicin med tillämpningar inom en mängd olika områden, såsom inom den marina sektorn, bland skadedjursbekämpning i skogs-och jordbruk, samt bland enskilda farmaceutiska arbetsområden. Verksamhet drivs på global nivå, med huvudkontoret i Malmö.
2024-06-07 10:15:00

The nomination committee, which consists of Anders Månsson (LMK companies) and Torsten Helsing (Manakin LTD), proposes the following:

  • that lawyer Christian Lindhé or, in his absence, the person appointed by the board instead is elected as chairman of the meeting,
  • that the number of board members should be seven, without deputies,
  • that remuneration to the board is paid with six price base amounts to the chairman of the board and with three price base amounts each to the other board members,
  • that the board members Jan Gustavsson, Torsten Helsing Christian Månsson, Jørn H. Berthelsen and Edward van den Elsen are re-elected. Gunilla Savring has declined re-election.
  • that Michael Engström is elected as a new board member,
  • that Jan Gustavsson is re-elected as chairman of the board,
  • that the company must have an auditor, without deputies,
  • that the auditor's fee is paid according to an approved current account, and
  • that Mazars AB be re-elected as the company's auditor, whereby the intention is that the authorized auditor Annika Larsson will be the auditor in charge.

The nomination committee further proposes that Anders Månsson (LMK companies) and Torsten Helsing (Manakin LTD) be re-elected as members of the nomination committee ahead of the 2025 annual general meeting, and that the nomination committee should have the opportunity to decide to appoint a third member to the nomination committee, as a representative of the company's other shareholders. Such possible third member must be appointed by the chairman of the board.

Information about the board member proposed for re-election
The nomination committee proposes the re-election of Michael Engström. Michael Engström, born 1963, is CEO and co-owner of the consulting and training company Ahrens & Partners AB. He is chairman of the board of Clemondo Group AB (publ), Hammerglass AB, Här Malmö AB and board member of Gullberg & Jansson AB (publ). Michael has over 20 years of experience in sales, marketing and as CEO of several companies, both in Sweden and during his 14 years abroad, for example Axis, Audiodev and Avery-Dennison. He is a marketing economist from Lund University and has an MBA from the University of Sheffield.

___________________

Lund in June 2024

aXichem AB (publ)

The nomination committee

The information was submitted, through the agency of the contact person, for publication on June 7, 2024, at 10:15 AM CET.

For further information:

Torsten Helsing, CEO, aXichem AB, phone: +46 706 863 355, email: torsten.helsing@axichem.com

About aXichem

aXichem develops, patents and markets natural analogue industrial chemicals, i.e., synthetically produced substances that have similar and comparable properties to natural substances. The company's first product is phenylcapsaicin, which the company commercializes under two brands, aXiphen® and aXivite®, as an ingredient in animal feed and dietary supplements, respectively. The business is divided into three market areas with different applications for phenylcapsaicin: as an ingredient in feed for poultry, such as chicken and turkey; as an ingredient in food supplements for gut health, weight control and sports and exercise; and as an ingredient in food supplements for the bio-enhancement of curcumin and melatonin. aXichem is listed on the Nasdaq First North Growth Market. More information is available at www.axichem.com.